Market Cap | 9.24B | P/E | 40.55 | EPS this Y | -37.00% | Ern Qtrly Grth | - |
Income | 243.88M | Forward P/E | 50.85 | EPS next Y | 24.00% | 50D Avg Chg | -10.00% |
Sales | 671.28M | PEG | 37.78 | EPS past 5Y | - | 200D Avg Chg | 4.00% |
Dividend | N/A | Price/Book | 16.17 | EPS next 5Y | 1.30% | 52W High Chg | -21.00% |
Recommedations | 2.20 | Quick Ratio | 12.99 | Shares Outstanding | 36.90M | 52W Low Chg | 46.00% |
Insider Own | 1.18% | ROA | 10.50% | Shares Float | 36.46M | Beta | 0.87 |
Inst Own | 93.29% | ROE | 50.96% | Shares Shorted/Prior | 1.61M/1.69M | Price | 252.23 |
Gross Margin | 86.95% | Profit Margin | 36.33% | Avg. Volume | 563,770 | Target Price | 234.36 |
Oper. Margin | 23.83% | Earnings Date | Feb 14 | Volume | 408,157 | Change | -2.90% |
ShockWave Medical, Inc., a medical device company, develops intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters for use in our IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter for use in IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
Morgan Stanley | Overweight | Dec 4, 23 |
Morgan Stanley | Overweight | Nov 7, 23 |
Needham | Buy | Nov 7, 23 |
Needham | Buy | Oct 24, 23 |
Leerink Partners | Outperform | Oct 16, 23 |
UBS | Neutral | Sep 29, 23 |
Morgan Stanley | Overweight | Aug 10, 23 |
Wells Fargo | Equal-Weight | Aug 8, 23 |
Needham | Buy | Aug 8, 23 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Zacharias Isaac | President, CCO President, CCO | Nov 27 | Sell | 173.58 | 4,000 | 694,320 | 43,868 | 11/28/23 |
Zacharias Isaac | President, CCO President, CCO | Nov 27 | Option | 6.71 | 3,777 | 25,344 | 47,868 | 11/28/23 |
WATKINS FRANK T | Director Director | Nov 20 | Sell | 173.11 | 3,000 | 519,330 | 1,532 | 11/21/23 |
WATKINS FRANK T | Director Director | Nov 20 | Option | 3.42 | 3,000 | 10,260 | 4,532 | 11/21/23 |
Godshall Douglas Evan | President & CEO President & CEO | Nov 15 | Sell | 174.38 | 5,000 | 871,900 | 136,057 | 11/17/23 |
Godshall Douglas Evan | President & CEO President & CEO | Nov 15 | Option | 3.42 | 5,000 | 17,100 | 141,057 | 11/17/23 |
Phung Trinh | VP, Finance VP, Finance | Apr 26 | Option | 3.42 | 2,400 | 8,208 | 31,095 | 11/03/23 |
Zacharias Isaac | President, CCO President, CCO | Oct 26 | Sell | 210.25 | 4,000 | 841,000 | 44,316 | 10/30/23 |
Zacharias Isaac | President, CCO President, CCO | Oct 26 | Option | 6.71 | 411 | 2,758 | 48,316 | 10/30/23 |
WATKINS FRANK T | Director Director | Oct 20 | Sell | 203.14 | 3,000 | 609,420 | 1,532 | 10/23/23 |
WATKINS FRANK T | Director Director | Oct 20 | Option | 3.42 | 3,000 | 10,260 | 4,532 | 10/23/23 |
Godshall Douglas Evan | President & CEO President & CEO | Oct 16 | Option | 3.42 | 10,000 | 34,200 | 151,649 | 10/17/23 |
Godshall Douglas Evan | President & CEO President & CEO | Oct 16 | Sell | 199.71 | 10,000 | 1,997,100 | 141,649 | 10/17/23 |
Zacharias Isaac | President, CCO President, CCO | Sep 26 | Sell | 192.12 | 4,000 | 768,480 | 47,905 | 09/27/23 |
WATKINS FRANK T | Director Director | Sep 20 | Sell | 209.23 | 3,000 | 627,690 | 1,532 | 09/21/23 |
WATKINS FRANK T | Director Director | Sep 20 | Option | 3.42 | 3,000 | 10,260 | 4,532 | 09/21/23 |
Godshall Douglas Evan | President & CEO President & CEO | Sep 15 | Sell | 212.62 | 10,000 | 2,126,200 | 141,649 | 09/19/23 |
Godshall Douglas Evan | President & CEO President & CEO | Sep 15 | Option | 3.42 | 10,000 | 34,200 | 151,649 | 09/19/23 |
Phung Trinh | VP, Finance VP, Finance | Aug 29 | Option | 3.416 | 5,000 | 17,080 | 25,986 | 08/31/23 |
Zacharias Isaac | President, CCO President, CCO | Aug 25 | Sell | 204.98 | 4,000 | 819,920 | 52,446 | 08/29/23 |
Godshall Douglas Evan | President & CEO President & CEO | Aug 24 | Sell | 212.95 | 10,000 | 2,129,500 | 141,649 | 08/25/23 |
Godshall Douglas Evan | President & CEO President & CEO | Aug 24 | Option | 3.42 | 10,000 | 34,200 | 151,649 | 08/25/23 |
FRANCIS LAURA | Director Director | Aug 22 | Sell | 220.97 | 497 | 109,822 | 3,054 | 08/23/23 |
WATKINS FRANK T | Director Director | Aug 21 | Sell | 218.97 | 3,000 | 656,910 | 1,532 | 08/22/23 |
WATKINS FRANK T | Director Director | Aug 21 | Option | 3.42 | 3,000 | 10,260 | 4,532 | 08/22/23 |
Toyloy Sara | Director Director | Aug 15 | Sell | 223.64 | 100 | 22,364 | 3,673 | 08/16/23 |
Zacharias Isaac | President, CCO President, CCO | Jul 26 | Sell | 268.06 | 4,000 | 1,072,240 | 56,678 | 07/27/23 |
WATKINS FRANK T | Director Director | Jul 20 | Sell | 267.11 | 3,000 | 801,330 | 1,532 | 07/21/23 |
WATKINS FRANK T | Director Director | Jul 20 | Option | 3.42 | 3,000 | 10,260 | 4,532 | 07/21/23 |
Papiernik Antoine | Director Director | Jul 05 | Option | 17.00 | 17,381 | 295,477 | 22,662 | 07/06/23 |
Zacharias Isaac | President, CCO President, CCO | Jun 26 | Sell | 291.84 | 4,000 | 1,167,360 | 60,678 | 06/26/23 |
Phung Trinh | VP, Finance VP, Finance | Jun 22 | Sell | 295.91 | 62 | 18,346 | 21,101 | 06/26/23 |
WATKINS FRANK T | Director Director | Jun 20 | Sell | 283.38 | 3,000 | 850,140 | 1,532 | 06/21/23 |
Zacharias Isaac | President, CCO President, CCO | May 26 | Sell | 277.53 | 4,000 | 1,110,120 | 65,223 | 05/30/23 |
WATKINS FRANK T | Director Director | May 22 | Sell | 278.21 | 3,000 | 834,630 | 3,796 | 05/23/23 |
WATKINS FRANK T | Director Director | May 22 | Option | 3.42 | 3,000 | 10,260 | 6,796 | 05/23/23 |
Toyloy Sara | Director Director | May 11 | Sell | 296.28 | 235 | 69,626 | 3,037 | 05/12/23 |
PUCKETT DAN | Chief Financial Offi.. Chief Financial Officer | May 11 | Sell | 291.95 | 2,050 | 598,498 | 29,398 | 05/12/23 |
Phung Trinh | VP, Finance VP, Finance | Apr 26 | Sell | 300.00 | 1,828 | 548,400 | 21,341 | 04/27/23 |
Zacharias Isaac | President, CCO President, CCO | Apr 26 | Sell | 289.00 | 4,000 | 1,156,000 | 69,454 | 04/26/23 |
WATKINS FRANK T | Director Director | Apr 20 | Sell | 261.13 | 3,000 | 783,390 | 3,796 | 04/21/23 |
WATKINS FRANK T | Director Director | Apr 20 | Option | 2.81 | 3,000 | 8,430 | 6,796 | 04/21/23 |
Phung Trinh | VP, Finance VP, Finance | Apr 18 | Sell | 264.67 | 251 | 66,432 | 23,169 | 04/19/23 |
PUCKETT DAN | Chief Financial Offi.. Chief Financial Officer | Apr 18 | Sell | 264.67 | 1,002 | 265,199 | 31,658 | 04/19/23 |
Zacharias Isaac | President, CCO President, CCO | Mar 27 | Sell | 215.69 | 4,000 | 862,760 | 74,078 | 03/28/23 |
PUCKETT DAN | Chief Financial Offi.. Chief Financial Officer | Mar 20 | Sell | 200.74 | 1,100 | 220,814 | 33,658 | 03/22/23 |
PUCKETT DAN | Chief Financial Offi.. Chief Financial Officer | Mar 20 | Option | 17 | 1,100 | 18,700 | 34,758 | 03/22/23 |
Zacharias Isaac | President, CCO President, CCO | Dec 27 | Sell | 209.59 | 4,000 | 838,360 | 87,021 | 03/21/23 |
WATKINS FRANK T | Director Director | Mar 20 | Sell | 200.47 | 3,000 | 601,410 | 3,796 | 03/21/23 |
WATKINS FRANK T | Director Director | Mar 20 | Option | 2.2 | 3,000 | 6,600 | 6,796 | 03/21/23 |